AR017221A1 - Compuestos abridores de los canales de potasio, y el uso de los mismos para la manufactura de un medicamento - Google Patents
Compuestos abridores de los canales de potasio, y el uso de los mismos para la manufactura de un medicamentoInfo
- Publication number
- AR017221A1 AR017221A1 ARP980106454A ARP980106454A AR017221A1 AR 017221 A1 AR017221 A1 AR 017221A1 AR P980106454 A ARP980106454 A AR P980106454A AR P980106454 A ARP980106454 A AR P980106454A AR 017221 A1 AR017221 A1 AR 017221A1
- Authority
- AR
- Argentina
- Prior art keywords
- ring
- group
- alkyl
- double bonds
- oxo substituents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
- C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
- C07C45/298—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with manganese derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Un compuesto abridor del canal de potasio, que comprende la formula (I) o su sal, éster, amida o profármaco farmacéuticamente aceptable donde R1 esalquilo; R2 se selecciona entre el grupo que consiste en arilo y heteroarilo; el arilo o heteroarilo está optativamente sustituido; n es 0-2; A se seleccionaentre el grupo que consiste en hidrogeno, alquilo y -X-R3; R3 es alquilo o haloalquilo; X es -C(O)- o -S(O)p-; p es 1-2; R4 y R5 se seleccionanindependientemente entre el grupo que consiste en hidrogeno, alquilo y haloalquilo; o R1 y R5 junto con el anillo al cual están unidos forman un anillo quecontiene azufre de 5, 6 o 7 miembros con 1-2 enlaces dobles y 0-2 sustituyentes oxo; o A y R4 junto con el anillo al cual están unidos forman un anilloseleccionado entre el grupo que consiste en un anillo carbocíclico de 5, 6 o 7 miembros con 1-2 enlaces dobles y 0-2 sustituyentes oxo y un anillo que contieneazufre de 5,6 o 7 miembros con 1-2 enlaces dobles y 0-2 sustituyentes oxo, siempre que por lo menos uno de R1 y R5 o A y R4 forme un anillo, son utilesen el tratamiento de enfermedades prevenidas por o mejoradas con abridores de locanales de potasio. También se describe el uso de los mismos para la manufactura de un medicamento util para abrir los canales de potasio para tratar unaenfermedad seleccionada del grupo que consiste en asma, epilepsia, hipertension, Síndrome de Raynaud, impotencia, migrana, dolor, trastornos de la alimentacionincontienencia urinaia, trastornos de intestino funcionales, neurodegeneracion y ataque apoplético.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99339297A | 1997-12-18 | 1997-12-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR017221A1 true AR017221A1 (es) | 2001-08-22 |
Family
ID=25539492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980106454A AR017221A1 (es) | 1997-12-18 | 1998-12-17 | Compuestos abridores de los canales de potasio, y el uso de los mismos para la manufactura de un medicamento |
Country Status (6)
Country | Link |
---|---|
US (1) | US6265417B1 (es) |
KR (1) | KR20010015881A (es) |
AR (1) | AR017221A1 (es) |
CO (1) | CO5040063A1 (es) |
TW (1) | TW593322B (es) |
ZA (1) | ZA9811591B (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001269529A1 (en) * | 2000-07-18 | 2002-01-30 | Yamanouchi Pharmaceutical Co., Ltd. | Medicine comprising dicyanopyridine derivative |
US6699892B2 (en) | 2002-06-04 | 2004-03-02 | Yung Shin Pharmaceutical Industrial Co., Ltd. | Pharmaceutically acceptable salt of amlodipine and method of preparing the same |
US20050089559A1 (en) * | 2003-10-23 | 2005-04-28 | Istvan Szelenyi | Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains |
US7960436B2 (en) * | 2006-06-05 | 2011-06-14 | Valeant Pharmaceuticals International | Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators |
US20080045534A1 (en) * | 2006-08-18 | 2008-02-21 | Valeant Pharmaceuticals North America | Derivatives of 1,3-diamino benzene as potassium channel modulators |
BRPI0716715B1 (pt) * | 2006-08-23 | 2021-07-06 | Xenon Pharmaceuticals, Inc | Derivados de 4-(n-azacicloalquil) anilidas como moduladores de canal de potássio, seus usos, produto, composição, comprimido e cápsula |
US8993593B2 (en) * | 2006-08-23 | 2015-03-31 | Valeant Pharmaceuticals International | N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators |
US8722929B2 (en) * | 2006-10-10 | 2014-05-13 | Valeant Pharmaceuticals International | N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators |
KR20090083479A (ko) | 2006-11-28 | 2009-08-03 | 밸리언트 파마슈티컬즈 인터내셔널 | 칼륨 채널 조절제로서의 1,4 디아미노 이환 레티가빈 유사체 |
US8367684B2 (en) * | 2007-06-13 | 2013-02-05 | Valeant Pharmaceuticals International | Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators |
US8563566B2 (en) | 2007-08-01 | 2013-10-22 | Valeant Pharmaceuticals International | Naphthyridine derivatives as potassium channel modulators |
US7786146B2 (en) * | 2007-08-13 | 2010-08-31 | Valeant Pharmaceuticals International | Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators |
MX2013005694A (es) * | 2010-12-23 | 2013-07-05 | Basf Se | Piridinas sustituidas que tienen accion herbicida. |
EP2773764A4 (en) * | 2011-11-02 | 2015-11-11 | Basf Se | PLANTS WITH INCREASED TOLERANCE TO HERBICIDES |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2616995A1 (de) | 1976-04-17 | 1977-10-27 | Bayer Ag | 1.4-dihydropyridine mit schwefelhaltigen substituenten mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
DE2658804A1 (de) | 1976-12-24 | 1978-07-06 | Bayer Ag | Kreislaufbeeinflussende mittel |
DE2747513A1 (de) | 1977-10-22 | 1979-05-03 | Bayer Ag | Dihydropyridine mit schwefelhaltigen estergruppierungen |
NZ201395A (en) * | 1981-07-30 | 1987-02-20 | Bayer Ag | Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines |
EP0145956A1 (de) | 1983-11-16 | 1985-06-26 | Ciba-Geigy Ag | Neue Amid-Verbindungen |
DE3501695A1 (de) | 1985-01-19 | 1986-07-24 | Bayer Ag, 5090 Leverkusen | Verwendung von sulfonyl-dihydropyridinen als arzneimittel zur behandlung von asthma |
US4777167A (en) | 1986-04-09 | 1988-10-11 | Ortho Pharmaceutical Corporation | Pharmaceutically useful substituted thiacycloalkeno [3,2-b]pyridines, compositions and method of use |
US4879384A (en) | 1988-06-15 | 1989-11-07 | Ortho Pharmaceutical Corporation | Preparation of thiocycloalkno [3,2-b] pyridines |
JPH032161A (ja) | 1989-05-31 | 1991-01-08 | Fujirebio Inc | 1,4―ジヒドロピリジン誘導体 |
US5075440A (en) | 1990-05-03 | 1991-12-24 | Ortho Pharmaceutical Corporation | Novel pyrido[2,3-f](1,4)thiazepines and pyrido[3,2-b](1,5)benzothiazepines |
CN1060467A (zh) * | 1990-09-25 | 1992-04-22 | 武田药品工业株式会社 | 1,3-苯并嗪衍生物、其生产方法和用途 |
EP0539154B1 (en) | 1991-10-21 | 1997-12-29 | Zeneca Limited | Acridine-1,8-dione-derivatives as therapeutic agents |
US5455253A (en) * | 1992-10-20 | 1995-10-03 | Zeneca Limited | Heterocyclic derivatives |
GB9318935D0 (en) | 1992-10-20 | 1993-10-27 | Zeneca Ltd | Heterocyclic derivatives |
DE4424678A1 (de) | 1994-07-13 | 1996-01-18 | Bayer Ag | Dioxo-thiopyrano-pyridin-carbonsäure-derivate |
DE4430092A1 (de) | 1994-08-25 | 1996-02-29 | Bayer Ag | 2,3-Cyclisch kondensierte 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
CA2314948A1 (en) | 1997-12-18 | 1999-06-24 | Abbott Laboratories | Potassium channel openers |
US6191140B1 (en) | 1998-10-28 | 2001-02-20 | Abbott Laboratories | Pyrano, piperidino, and thiopyrano compounds and methods of use |
US6518279B2 (en) | 1999-03-04 | 2003-02-11 | Abbott Laboratories | Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
-
1998
- 1998-12-04 US US09/206,055 patent/US6265417B1/en not_active Expired - Fee Related
- 1998-12-16 KR KR1020007006664A patent/KR20010015881A/ko not_active Application Discontinuation
- 1998-12-16 CO CO98074895A patent/CO5040063A1/es unknown
- 1998-12-17 AR ARP980106454A patent/AR017221A1/es not_active Application Discontinuation
- 1998-12-17 ZA ZA9811591A patent/ZA9811591B/xx unknown
-
1999
- 1999-02-12 TW TW087121225A patent/TW593322B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20010015881A (ko) | 2001-02-26 |
ZA9811591B (en) | 1999-06-17 |
US6265417B1 (en) | 2001-07-24 |
CO5040063A1 (es) | 2001-05-29 |
TW593322B (en) | 2004-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR017221A1 (es) | Compuestos abridores de los canales de potasio, y el uso de los mismos para la manufactura de un medicamento | |
AR004493A1 (es) | Derivados de oxindol 3- sustituido util como moduladores de canales de potasio y composiciones farmaceuticas que lo contienen. | |
NO20024042D0 (no) | Aryl-fusjonerte azapolysykliske forbindelser | |
LU90317I2 (fr) | Tacrolimus et ses sels et dérivés pharmaceutiquement acceptables | |
PE20040164A1 (es) | Mimeticos de glucocorticoides, procedimientos para su preparacion y composiciones farmaceuticas | |
CO5580815A2 (es) | Derivados de adamantana, procesos para su preparacion y composiciones farmaceuticas que los contienen | |
CA2280905A1 (en) | Highly lipophilic camptothecin derivatives | |
CO4950563A1 (es) | Nuevos compuestos | |
CA2013324A1 (fr) | Pteridin-4 (3h)-ones, procedes de preparation et medicaments les contenant | |
AR034156A1 (es) | Un compuesto retinoide, su uso, una composicion farmaceutica que lo comprende y procedimiento para la preparacion de un compuesto retinoide | |
DE69429570D1 (de) | Galanthamin Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente | |
MA28286A1 (fr) | Dérivés de 1-N-phenyl-amino-1H-imidazole et compositions pharmaceutiques les contenant | |
CO4940446A1 (es) | Compuestos 4-aminopirido[2,3-d]pirimidina 5,7-disustituidos | |
TNSN95039A1 (fr) | Derives de la 1,5 benzodiazepine | |
ATE204868T1 (de) | 2-aryl-3-aminoaryloxynaphthylverbindungen, zwischenverbindungen, zusammensetzungen und verfahren | |
AR011964A1 (es) | Un compuesto derivado de (1h-indol-2-il)-5-[(2h-pirrol-2-ilideno)metil]-1h- pirrol, su utilizacion, un procedimiento para producirlo, productos ycomposiciones farmaceuticas que comprenden a dicho compuesto, un compuesto util como intermediario para preparar a dicho compuesto y una preparacion de | |
Francisco et al. | Intramolecular 1, 5-hydrogen atom transfer reaction promoted by phosphoramidyl and carbamoyl radicals: synthesis of 2-amino-C-glycosides | |
MA27104A1 (fr) | Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
PE20010517A1 (es) | Las rutas sinteticas eficientes para la preparacion de los inhibidores de la proteasa del rinovirus y los intermedios claves | |
WO2006015318A2 (en) | Antibody conjugated to a drug moiety via a poptidic linker | |
HUP0302820A2 (hu) | CNS rendellenességek kezelésében hasznos indolszármazékok és ezeket tartalmazó gyógyszerkészítmények | |
FR2700165B1 (fr) | Dérivés de pyrrolidine, leur préparation et les médicaments les contenant. | |
MA27091A1 (fr) | Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
PE20001429A1 (es) | Derivados de higromicina como agentes antibacterianos | |
ATE24002T1 (de) | Dibenzoxepine, ihre herstellung, diese verbindungen enthaltende zusammensetzungen und ihre verwendung bei der behandlung von allergischen zustaenden. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |